GPI Monoclonal Antibody

This gene encodes a member of the glucose phosphate isomerase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In the cytoplasm, the gene product functions as a glycolytic enzyme (glucose-6-phosphate isomerase) that interconverts glucose-6-phosphate and fructose-6-phosphate. Extracellularly, the encoded protein (also referred to as neuroleukin) functions as a neurotrophic factor that promotes survival of skeletal motor neurons and sensory neurons, and as a lymphokine that induces immunoglobulin secretion. The encoded protein is also referred to as autocrine motility factor based on an additional function as a tumor-secreted cytokine and angiogenic factor. Defects in this gene are the cause of nonspherocytic hemolytic anemia and a severe enzyme deficiency can be associated with hydrops fetalis

The GPI Monoclonal Antibody is a highly specialized product that has been developed to target and bind to the glycosylphosphatidylinositol (GPI) anchor, a molecule that is found on the surface of many cells in the human body. This antibody has been extensively tested and validated for its specificity and efficacy in a range of applications, including research, diagnostics, and therapeutics.

The GPI Monoclonal Antibody is produced using state-of-the-art techniques and quality control measures to ensure that it meets the highest standards of purity and potency. It is available in a range of formats and quantities to suit the needs of different users, and can be customized to meet specific requirements.

This product has been shown to be highly effective in a range of applications, including the detection and quantification of GPI-anchored proteins, the isolation and purification of cells expressing GPI-anchored proteins, and the targeting of cancer cells that express GPI-anchored proteins. It has also been used in the development of novel therapeutics for a range of diseases, including cancer, autoimmune disorders, and infectious diseases.

Overall, the GPI Monoclonal Antibody is a highly valuable tool for researchers, clinicians, and pharmaceutical companies who are working to understand and treat a range of diseases. Its high specificity, potency, and versatility make it an essential component of many cutting-edge research and therapeutic programs.